scholarly article | Q13442814 |
P2093 | author name string | Göran Larson | |
Jonas Nilsson | |||
Johanna Nilsson | |||
Ammi Grahn | |||
P2860 | cites work | A comparative study of alpha-dystroglycan glycosylation in dystroglycanopathies suggests that the hypoglycosylation of alpha-dystroglycan does not consistently correlate with clinical severity | Q24321993 |
Mutations in the fukutin-related protein gene (FKRP) cause a form of congenital muscular dystrophy with secondary laminin alpha2 deficiency and abnormal glycosylation of alpha-dystroglycan | Q24535942 | ||
POMT2 mutations cause alpha-dystroglycan hypoglycosylation and Walker-Warburg syndrome | Q24674153 | ||
Dystroglycan is a binding protein of laminin and merosin in peripheral nerve | Q28238540 | ||
Refining genotype phenotype correlations in muscular dystrophies with defective glycosylation of dystroglycan | Q28249364 | ||
Human dystroglycan: skeletal muscle cDNA, genomic structure, origin of tissue specific isoforms and chromosomal localization | Q28257696 | ||
Primary structure of dystrophin-associated glycoproteins linking dystrophin to the extracellular matrix | Q28296676 | ||
Spectrum of brain changes in patients with congenital muscular dystrophy and FKRP gene mutations | Q28297242 | ||
Brain alpha-dystroglycan displays unique glycoepitopes and preferential binding to laminin-10/11 | Q28589413 | ||
Regulation of mammalian protein O-mannosylation: preferential amino acid sequence for O-mannose modification | Q33284581 | ||
O-mannosyl phosphorylation of alpha-dystroglycan is required for laminin binding. | Q34090655 | ||
The complexities of dystroglycan | Q34134645 | ||
Mouse large can modify complex N- and mucin O-glycans on alpha-dystroglycan to induce laminin binding | Q34405965 | ||
Mutational and functional analysis of Large in a novel CHO glycosylation mutant | Q34983110 | ||
Glycosylation in congenital muscular dystrophies | Q35596665 | ||
Dystroglycan: from biosynthesis to pathogenesis of human disease. | Q36367346 | ||
Multiple cell culture factors can affect the glycosylation of Asn-184 in CHO-produced tissue-type plasminogen activator | Q38309412 | ||
Enhanced laminin binding by alpha-dystroglycan after enzymatic deglycosylation | Q38326990 | ||
Structures of sialylated O-linked oligosaccharides of bovine peripheral nerve alpha-dystroglycan. The role of a novel O-mannosyl-type oligosaccharide in the binding of alpha-dystroglycan with laminin | Q38349218 | ||
Core 1 glycans on alpha-dystroglycan mediate laminin-induced acetylcholine receptor clustering but not laminin binding | Q38350844 | ||
Initiation of mammalian O-mannosylation in vivo is independent of a consensus sequence and controlled by peptide regions within and upstream of the alpha-dystroglycan mucin domain | Q39985380 | ||
Glycosylation of recombinant proteins: problems and prospects | Q40534646 | ||
Differential Vicia villosa agglutinin reactivity identifies three distinct dystroglycan complexes in skeletal muscle | Q40791672 | ||
Getting the glycosylation right: implications for the biotechnology industry | Q41176922 | ||
POMT2 mutation in a patient with 'MEB-like' phenotype. | Q41919601 | ||
The expanding phenotype of POMT1 mutations: from Walker-Warburg syndrome to congenital muscular dystrophy, microcephaly, and mental retardation. | Q41919724 | ||
Post-translational disruption of dystroglycan-ligand interactions in congenital muscular dystrophies | Q42524150 | ||
Mutations in the FKRP gene can cause muscle-eye-brain disease and Walker-Warburg syndrome. | Q43073716 | ||
The phenotype of limb-girdle muscular dystrophy type 2I | Q44411539 | ||
LARGE can functionally bypass alpha-dystroglycan glycosylation defects in distinct congenital muscular dystrophies. | Q47375901 | ||
Phenotypic spectrum associated with mutations in the fukutin-related protein gene | Q48350456 | ||
Structural analysis of sequences O-linked to mannose reveals a novel Lewis X structure in cranin (dystroglycan) purified from sheep brain | Q48401243 | ||
Tissue-specific heterogeneity in alpha-dystroglycan sialoglycosylation. Skeletal muscle alpha-dystroglycan is a latent receptor for Vicia villosa agglutinin b4 masked by sialic acid modification | Q48634703 | ||
P433 | issue | 9 | |
P304 | page(s) | 1160-1169 | |
P577 | publication date | 2010-05-27 | |
P1433 | published in | Glycobiology | Q5572596 |
P1476 | title | Characterization of site-specific O-glycan structures within the mucin-like domain of alpha-dystroglycan from human skeletal muscle | |
P478 | volume | 20 |
Q28485391 | A Method to Produce and Purify Full-Length Recombinant Alpha Dystroglycan: Analysis of N- and O-Linked Monosaccharide Composition in CHO Cells with or without LARGE Overexpression |
Q28511766 | AGO61-dependent GlcNAc modification primes the formation of functional glycans on α-dystroglycan |
Q46846034 | Analysis of mammalian O-glycopeptides - we have made a good start, but there is a long way to go. |
Q30400284 | Biochemical correlation of activity of the α-dystroglycan-modifying glycosyltransferase POMGnT1 with mutations in muscle-eye-brain disease. |
Q36217346 | Developmental expression of the neuron-specific N-acetylglucosaminyltransferase Vb (GnT-Vb/IX) and identification of its in vivo glycan products in comparison with those of its paralog, GnT-V |
Q37609175 | Dissecting the molecular basis of the role of the O-mannosylation pathway in disease: α-dystroglycan and forms of muscular dystrophy |
Q38932357 | Distinctive MS/MS Fragmentation Pathways of Glycopeptide-Generated Oxonium Ions Provide Evidence of the Glycan Structure. |
Q33633266 | Efficacy of Gene Therapy Is Dependent on Disease Progression in Dystrophic Mice with Mutations in the FKRP Gene |
Q30578276 | Glycobioinformatics: current strategies and tools for data mining in MS-based glycoproteomics |
Q34126184 | Glycoproteomic characterization of recombinant mouse α-dystroglycan |
Q36033160 | Glycosylation of α-dystroglycan: O-mannosylation influences the subsequent addition of GalNAc by UDP-GalNAc polypeptide N-acetylgalactosaminyltransferases |
Q37712517 | High-sensitivity analytical approaches for the structural characterization of glycoproteins |
Q34288440 | Human natural killer-1 sulfotransferase (HNK-1ST)-induced sulfate transfer regulates laminin-binding glycans on α-dystroglycan |
Q36543504 | Immunologic mapping of glycomes: implications for cancer diagnosis and therapy |
Q38701314 | Liquid chromatography-tandem mass spectrometry-based fragmentation analysis of glycopeptides |
Q33882060 | Mammalian O-mannosylation of cadherins and plexins is independent of protein O-mannosyltransferases 1 and 2. |
Q38208557 | Mammalian O-mannosylation pathway: glycan structures, enzymes, and protein substrates |
Q26860991 | Mammalian O-mannosylation: unsolved questions of structure/function |
Q38424785 | Matriglycan: a novel polysaccharide that links dystroglycan to the basement membrane. |
Q39461034 | Mining the O-glycoproteome using zinc-finger nuclease-glycoengineered SimpleCell lines |
Q37421355 | Mining the O-mannose glycoproteome reveals cadherins as major O-mannosylated glycoproteins |
Q24294992 | Mutations in GDP-mannose pyrophosphorylase B cause congenital and limb-girdle muscular dystrophies associated with hypoglycosylation of α-dystroglycan |
Q27014986 | O-Mannosylation and human disease |
Q39369642 | O-linked N,N'-diacetyllactosamine (LacdiNAc)-modified glycans in extracellular matrix glycoproteins are specifically phosphorylated at subterminal N-acetylglucosamine |
Q30590282 | POMK mutations disrupt muscle development leading to a spectrum of neuromuscular presentations |
Q34788338 | Probing the stability of the "naked" mucin-like domain of human α-dystroglycan |
Q46448834 | Protein O-Linked Mannose β-1,4-N-Acetylglucosaminyl-transferase 2 (POMGNT2) Is a Gatekeeper Enzyme for Functional Glycosylation of α-Dystroglycan |
Q40092479 | Recent advancements in understanding mammalian O-mannosylation |
Q89964316 | Remarkable Homeostasis of Protein Sialylation in Skeletal Muscles of Hibernating Daurian Ground Squirrels (Spermophilus dauricus) |
Q34656853 | Structural glycomic analyses at high sensitivity: a decade of progress |
Q35222634 | Synthetic, structural, and biosynthetic studies of an unusual phospho-glycopeptide derived from α-dystroglycan |
Q36554714 | Targeting the glycoproteome |
Q36666131 | The o-mannosylation pathway: glycosyltransferases and proteins implicated in congenital muscular dystrophy |
Q47106698 | The significance of post-translational removal of α-DG-N in early stage endometrial cancer development. |
Q28592706 | Xylosyl- and glucuronyltransferase functions of LARGE in α-dystroglycan modification are conserved in LARGE2 |
Search more.